Terms: = Uterine cancer AND CBL, RNF55, 867, ENSG00000110395, C-CBL, CBL2 AND Treatment
10 results:
1. Homologous Recombination Deficiency Testing to Inform Patient Decisions About Niraparib Maintenance Therapy for High-Grade Serous or Endometrioid Epithelial Ovarian cancer: A Health Technology Assessment.
Ontario Health (Quality)
Ont Health Technol Assess Ser; 2023; 23(5):1-188. PubMed ID: 37637244
[TBL] [Abstract] [Full Text] [Related]
2. A Scoring System to Select the Candidates for Adjuvant Chemotherapy Alone in High-Risk Early-Stage Cervical cancer Patients With Pelvic Lymph Node Metastases After Surgery.
Yang XL; Yang FL; Wang N; Zhang YE; Kou LN; Wu DJ; Luo Y
Am J Clin Oncol; 2023 May; 46(5):219-224. PubMed ID: 36877193
[TBL] [Abstract] [Full Text] [Related]
3. A phase 2 evaluation of pembrolizumab for recurrent Lynch-like versus sporadic endometrial cancers with microsatellite instability.
Bellone S; Roque DM; Siegel ER; Buza N; Hui P; Bonazzoli E; Guglielmi A; Zammataro L; Nagarkatti N; Zaidi S; Lee J; Silasi DA; Huang GS; Andikyan V; Damast S; Clark M; Azodi M; Schwartz PE; Tymon-Rosario JR; Harold JA; Mauricio D; Zeybek B; Menderes G; Altwerger G; Ratner E; Alexandrov LB; Iwasaki A; Kong Y; Song E; Dong W; Elvin JA; Choi J; Santin AD
Cancer; 2022 Mar; 128(6):1206-1218. PubMed ID: 34875107
[TBL] [Abstract] [Full Text] [Related]
4. Novel strategy to treat lung metastases: Hybrid therapy involving surgery and radiofrequency ablation.
Hasegawa T; Kuroda H; Sakakura N; Sato Y; Chatani S; Murata S; Yamaura H; Nakada T; Oya Y; Inaba Y
Thorac Cancer; 2021 Jul; 12(14):2085-2092. PubMed ID: 34106518
[TBL] [Abstract] [Full Text] [Related]
5. Use of Ulipristal Acetate and Risk of Liver Disease: A Nationwide Cohort Study.
Yoon EL; Yuk JS
J Clin Endocrinol Metab; 2021 May; 106(6):1773-1782. PubMed ID: 33567071
[TBL] [Abstract] [Full Text] [Related]
6. [cancers in systemic sclerosis : risk factors, impact on survival and literature review].
Catano J; Guedon A; Riviere S; Carrat F; Mahevas T; Fain O; Mekinian A
Rev Med Interne; 2019 Oct; 40(10):637-644. PubMed ID: 31255252
[TBL] [Abstract] [Full Text] [Related]
7. Population-level scale-up of cervical cancer prevention services in a low-resource setting: development, implementation, and evaluation of the cervical cancer prevention program in Zambia.
Parham GP; Mwanahamuntu MH; Kapambwe S; Muwonge R; Bateman AC; Blevins M; Chibwesha CJ; Pfaendler KS; Mudenda V; Shibemba AL; Chisele S; Mkumba G; Vwalika B; Hicks ML; Vermund SH; Chi BH; Stringer JS; Sankaranarayanan R; Sahasrabuddhe VV
PLoS One; 2015; 10(4):e0122169. PubMed ID: 25885821
[TBL] [Abstract] [Full Text] [Related]
8. Trabectedin in combination with doxorubicin for first-line treatment of advanced uterine or soft-tissue leiomyosarcoma (LMS-02): a non-randomised, multicentre, phase 2 trial.
Pautier P; Floquet A; Chevreau C; Penel N; Guillemet C; Delcambre C; Cupissol D; Selle F; Isambert N; Piperno-Neumann S; Thyss A; Bertucci F; Bompas E; Alexandre J; Collard O; Lavau-Denes S; Soulié P; Toulmonde M; Le Cesne A; Lacas B; Duffaud F;
Lancet Oncol; 2015 Apr; 16(4):457-64. PubMed ID: 25795402
[TBL] [Abstract] [Full Text] [Related]
9. [Estimation of the treatment cost of cervical cancer].
el M'Rini T; Arveux P; Gay C; Woronoff-Lemsi MC; Gautier C; Gaillard A; Maillet R; Schraub S
Rev Epidemiol Sante Publique; 1997 Dec; 45(6):508-15. PubMed ID: 9496581
[TBL] [Abstract] [Full Text] [Related]
10. Objective results of the operative treatment of cervical cancer.
Burghardt E; Pickel H; Haas J; Lahousen M
Baillieres Clin Obstet Gynaecol; 1988 Dec; 2(4):987-95. PubMed ID: 3229067
[TBL] [Abstract] [Full Text] [Related]